查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088627

青光眼手術醫療設備市場：2026-2032年全球市場預測（依產品類型、適應症類型、材質類型、最終用戶和分銷管道分類）

Glaucoma Surgery Devices Market by Product Type, Indication Type, Material Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，青光眼手術器械市場規模將成長至 16.5 億美元，複合年成長率為 7.40%。

主要市場統計數據
基準年 2025 10億美元
預計年份：2026年 10.6億美元
預測年份 2032 16.5億美元
複合年成長率 (%) 7.40%

青光眼手術用醫療設備市場概覽

青光眼手術器械正從專科醫生專屬的治療領域，轉向更廣泛的視力保護平台轉變，這一轉變源於人們對早期診斷、延長使用壽命和更安全的眼壓管理的需求。青光眼是導致不可逆性失明的主要原因之一，經同儕審查的流行病學研究預測，青光眼患者人數將從2020年的約7,600萬增加到2040年的約1.12億人。

青光眼手術醫療設備市場發生變革性變化

青光眼手術器械的模式正在重塑，治療重點從晚期侵入性手術轉向早期、對患者身體負擔較小的治療。微創青光眼手術拓寬了治療選擇，尤其適用於同時接受白內障手術的輕度至中度開放性青光眼患者。然而，對於晚期和難治性病例，引流管植入術和濾過手術仍然至關重要。

人工智慧在青光眼手術中的累積影響

人工智慧（AI）不會取代青光眼外科醫生，但它正在改變青光眼手術器械選擇的決策格局。人工智慧驅動的光學同調斷層掃描（OCT）、視神經成像、視野檢查和電子健康記錄分析有助於早期風險分層，並幫助識別那些儘管接受藥物治療和雷射治療，病情仍可能進展的患者。

關於青光眼手術器械的關鍵區域性見解

由於中國、印度、日本、韓國和澳洲等國的青光眼負擔沉重，亞太地區預計將長期佔據最大的市場規模。這與這些國家的人口規模、人口老化以及眼科醫療體系的擴張密切相關。儘管白內障手術能力的提升、都市區專業眼科醫院的增多以及公共防盲計畫的開展，使得手術機會日益增多，但不同地區的成本效益和熟練青光眼外科醫生的可及性仍然存在差異。北美地區仍然是一個高價值的創新區域，這得益於FDA的核准流程、專業的青光眼診療、門診手術中心以及對高階白內障和青光眼手術的積極推廣。

關於青光眼手術器械引入的關鍵群體分析

東協市場的特點是保險報銷體係不均衡，且私人眼科醫療產業持續擴張。在新加坡、泰國、馬來西亞、印尼、越南和菲律賓，眼科手術器材的推廣應用路徑因專科醫生密度、醫院投資和醫療旅遊發展狀況而異。在海灣合作理事會（GCC）國家，先進的醫院基礎設施和引進的專業技術備受重視，臨床教育、監管準備以及銷售代理的實力對於青光眼手術醫療設備的商業化至關重要。

各國青光眼手術器械的關鍵訊息

由於美國擁有高密度的專科醫生、經FDA批准的臨床證據、門診手術能力以及青光眼和白內障手術的整合，因此在許多青光眼手術醫療設備的商業化方面處於領先地位。另一方面，加拿大則更重視省級醫保報銷體系、醫療技術評估和實證醫學的應用。墨西哥和巴西由於私營部門的蓬勃發展和眼科服務的擴張，擁有大規模的患者群體，但醫療費用、醫療覆蓋範圍不均以及公共醫療服務的可及性仍然是重大挑戰。

為行業領導者提供的實用建議

產業領導者應優先考慮差異化的臨床證據，這些證據需證明產品能持續控制眼壓、減輕用藥負擔、持久有效，並能適用於不同嚴重程度的青光眼。在醫療設備組合中，針對晚期疾病的微創解決方案和技術應進行整合，而非視為相互競爭的類別，使外科醫生能夠根據疾病分期、解剖特徵、風險狀況和既往治療史選擇合適的手術方案。

調查方法

本執行摘要基於三角測量法的研究途徑，該方法結合了同行評審的青光眼流行病學研究、眼科學會指南、監管資訊、臨床試驗證據、保險報銷趨勢、公共衛生數據以及區域醫療基礎設施分析。研究結果根據已建立的臨床事實進行評估，例如降低眼內壓在延緩青光眼進展中的核心作用。

結論

隨著全球青光眼負擔日益加重，臨床醫生對更安全、更早、更持久的眼壓降低療法的需求不斷成長，青光眼手術醫療設備市場預計將繼續保持其重要性。雖然微創青光眼手術正在擴大合格的患者接受手術治療的機會，但傳統的濾過和引流醫療設備對於重症、複雜和難治性病例仍然至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：青光眼手術醫療設備市場：依產品類型分類

  • 青光眼引流裝置
    • 閥門
    • 引流植入
    • 支架
  • 用於微創青光眼手術的醫療設備
  • 雷射設備

第8章：青光眼手術醫療設備市場：依適應症類型分類

  • 開放性青光眼
  • 隅角閉鎖性青光眼

第9章：青光眼手術醫療設備市場：依材料類型分類

  • 矽基設備
  • 聚丙烯裝置
  • 可生物分解聚合物

第10章：青光眼手術醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 眼科診所
  • 學術機構

第11章：青光眼手術醫療設備市場：依分銷管道分類

  • 線上銷售
  • 線下銷售

第12章：青光眼手術醫療設備市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：青光眼手術醫療設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：青光眼手術醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Alcon Inc.
  • Bausch & Lomb Incorporated
  • Carl Zeiss Meditec AG
  • Ellex Medical Lasers Ltd.
  • Glaukos Corporation
  • Implandata Ophthalmic Products GmbH
  • Iridex Corporation
  • iSTAR Medical SA
  • Johnson & Johnson Vision Care, Inc.
  • Lumenis Ltd.
  • Medicontur International Zrt.
  • MicroSurgical Technology, Inc.
  • New World Medical, Inc.
  • NIDEK Co., Ltd.
  • Santen Pharmaceutical Co., Ltd.
  • Sight Sciences, Inc.
  • STAAR Surgical Company
Product Code: MRR-A339DAEF9D8F

The Glaucoma Surgery Devices Market is projected to grow by USD 1.65 billion at a CAGR of 7.40% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.00 billion
Estimated Year [2026] USD 1.06 billion
Forecast Year [2032] USD 1.65 billion
CAGR (%) 7.40%

Glaucoma Surgery Devices Market Introduction

Glaucoma surgery devices are moving from a specialist-only intervention category to a broader sight-preservation platform shaped by earlier diagnosis, longer life expectancy, and demand for safer intraocular pressure control. Glaucoma is a leading cause of irreversible blindness, and peer-reviewed epidemiology has projected the number of people with glaucoma to rise from about 76 million in 2020 to nearly 112 million by 2040.

The market is anchored by the clinical reality that lowering intraocular pressure remains the only proven modifiable strategy to slow glaucoma progression. This keeps trabeculectomy devices, glaucoma drainage implants, micro-invasive glaucoma surgery devices, canal-based systems, cyclophotocoagulation platforms, and combined cataract-glaucoma procedures central to ophthalmic surgical planning.

Transformative Shifts in the Glaucoma Surgery Device Landscape

The glaucoma surgery devices landscape is being reshaped by the shift from late-stage invasive surgery toward earlier, lower-trauma intervention. Micro-invasive glaucoma surgery has expanded the treatment continuum, particularly for mild-to-moderate open-angle glaucoma patients undergoing cataract surgery, while tube shunts and filtering procedures remain essential for advanced and refractory disease.

Regulatory rigor, surgeon training, real-world evidence, and reimbursement scrutiny are becoming decisive market forces. Hospitals and ambulatory surgery centers increasingly evaluate devices not only on pressure reduction, but also on safety profile, medication burden reduction, procedure time, durability, and fit with outpatient ophthalmology workflows.

Cumulative Impact of Artificial Intelligence on Glaucoma Surgery

Artificial intelligence is not replacing glaucoma surgeons, but it is changing the decision environment around glaucoma surgery devices. AI-enabled analysis of optical coherence tomography, optic nerve images, visual fields, and electronic health records can support earlier risk stratification and help identify patients likely to progress despite medication or laser therapy.

The cumulative impact is expected to be strongest in referral timing, surgical planning, post-operative monitoring, and outcomes analytics. AI can help manufacturers and providers generate real-world evidence on intraocular pressure reduction, complication rates, and medication reduction, but adoption depends on clinical validation, explainability, cybersecurity, and compliance with medical device software regulations.

Key Regional Insights Across Glaucoma Surgery Devices

Asia-Pacific represents the largest long-term volume opportunity because glaucoma burden is linked to population scale, aging demographics, and expanding ophthalmology capacity in China, India, Japan, South Korea, and Australia. Rising cataract surgery capacity, urban specialty eye hospitals, and public blindness-prevention programs are supporting wider procedural access, although affordability and trained glaucoma surgeon availability remain uneven across the region. North America remains a high-value innovation region, supported by FDA pathways, specialist glaucoma practices, ambulatory surgery centers, and strong adoption of premium cataract and glaucoma procedures.

Europe is shaped by CE marking, Medical Device Regulation requirements, and country-level health technology assessment, creating demand for strong clinical evidence, post-market surveillance, and payer-relevant outcome data. Latin America shows opportunity through Brazil and Mexico, where private ophthalmology networks and cataract surgery demand support adoption, although access and reimbursement vary widely. The Middle East, led by GCC investment in specialty hospitals and imported ophthalmic technologies, is modernizing glaucoma care, while Africa remains underpenetrated due to limited screening, surgical capacity, specialist distribution, and affordability constraints.

Key Group Insights for Glaucoma Surgery Device Adoption

ASEAN markets are characterized by uneven reimbursement and a growing private ophthalmology sector, with Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines offering different routes to adoption based on specialist density, hospital investment, and medical tourism. GCC countries favor advanced hospital infrastructure and imported specialty technologies, making clinical education, regulatory readiness, and distributor strength critical for glaucoma surgery device commercialization.

The European Union rewards evidence-backed devices that can meet MDR documentation, clinical evaluation, vigilance, and post-market surveillance expectations. BRICS countries combine high patient volumes with cost sensitivity and variable public procurement systems, making scalable device economics and local clinical training important. G7 markets lead in clinical research, reimbursement debates, and premium technology adoption, while NATO countries provide overlapping demand through resilient healthcare infrastructure, standardized quality expectations, and procurement standards across many advanced health systems.

Key Country Insights in Glaucoma Surgery Devices

The United States leads commercialization for many glaucoma surgery devices due to specialist density, FDA-recognized clinical evidence, ambulatory procedure capacity, and integration of glaucoma procedures with cataract surgery, while Canada emphasizes provincial reimbursement, health technology evaluation, and evidence-based adoption. Mexico and Brazil offer large patient pools with private-sector momentum and expanding ophthalmology services, but affordability, uneven insurance coverage, and public-sector access remain important.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine advanced ophthalmology networks with strict evidence expectations, payer scrutiny, and growing interest in procedures that reduce medication burden. Russia faces more variable access, regional procurement complexity, and dependence on hospital-level investment. China and India represent major volume opportunities due to population scale, aging demographics, and expanding eye-care infrastructure; Japan and South Korea support high-quality device adoption through advanced ophthalmic practice and technology-oriented care pathways; and Australia benefits from organized specialist care, established cataract-glaucoma surgical pathways, and a well-developed private ophthalmology sector.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated clinical evidence that proves sustained intraocular pressure control, medication burden reduction, durability, and safety across diverse glaucoma severities. Device portfolios should align micro-invasive solutions with advanced disease technologies rather than treating them as competing categories, ensuring surgeons can match procedures to disease stage, anatomy, risk profile, and prior treatment history.

Manufacturers should strengthen surgeon education, post-market registries, payer dossiers, regulatory documentation, and partnerships with cataract surgery networks. Regional strategies should balance premium positioning in North America, Japan, Australia, and Western Europe with value-engineered access models in India, China, Latin America, ASEAN, Africa, and parts of the Middle East, supported by training programs and service infrastructure.

Research Methodology

This executive summary is built on a triangulated research approach using peer-reviewed glaucoma epidemiology, ophthalmology society guidance, regulatory intelligence, clinical trial evidence, reimbursement patterns, public health data, and regional healthcare infrastructure analysis. Insights are assessed against established clinical facts, including the central role of intraocular pressure reduction in slowing glaucoma progression.

The methodology evaluates device demand through segmentation by procedure type, care setting, geography, adoption barriers, regulatory pathways, and competitive positioning. It emphasizes validated public sources, expert interpretation, and cross-checking of clinical and commercial signals to avoid reliance on unverified claims, market sizing, or unsupported projections.

Conclusion

The glaucoma surgery devices market is positioned for sustained relevance as the global glaucoma burden rises and clinicians seek safer, earlier, and more durable pressure-lowering interventions. Micro-invasive glaucoma surgery is expanding access to procedural care for appropriate patients, while traditional filtration and drainage devices remain indispensable for severe, complex, and refractory disease.

Future performance will depend on evidence quality, surgeon confidence, reimbursement alignment, AI-enabled care pathways, regulatory compliance, and geographic access strategies. Organizations that combine clinical rigor with scalable commercialization and strong training support will be best positioned to advance glaucoma care and help protect vision worldwide.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Glaucoma Surgery Devices Market, by Product Type

  • 7.1. Glaucoma Drainage Devices
    • 7.1.1. Valves
    • 7.1.2. Drainage Implants
    • 7.1.3. Stents
  • 7.2. Minimally Invasive Glaucoma Surgery Devices
  • 7.3. Laser Based Devices

8. Glaucoma Surgery Devices Market, by Indication Type

  • 8.1. Open Angle Glaucoma
  • 8.2. Closed Angle Glaucoma

9. Glaucoma Surgery Devices Market, by Material Type

  • 9.1. Silicone Based Devices
  • 9.2. Polypropylene Devices
  • 9.3. Biodegradable Polymers

10. Glaucoma Surgery Devices Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Hospitals
  • 10.3. Ophthalmic Clinics
  • 10.4. Academic Institutions

11. Glaucoma Surgery Devices Market, by Distribution Channel

  • 11.1. Online Sales
  • 11.2. Offline Sales

12. Glaucoma Surgery Devices Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Glaucoma Surgery Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Glaucoma Surgery Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Alcon Inc.
  • 16.3. Bausch & Lomb Incorporated
  • 16.4. Carl Zeiss Meditec AG
  • 16.5. Ellex Medical Lasers Ltd.
  • 16.6. Glaukos Corporation
  • 16.7. Implandata Ophthalmic Products GmbH
  • 16.8. Iridex Corporation
  • 16.9. iSTAR Medical SA
  • 16.10. Johnson & Johnson Vision Care, Inc.
  • 16.11. Lumenis Ltd.
  • 16.12. Medicontur International Zrt.
  • 16.13. MicroSurgical Technology, Inc.
  • 16.14. New World Medical, Inc.
  • 16.15. NIDEK Co., Ltd.
  • 16.16. Santen Pharmaceutical Co., Ltd.
  • 16.17. Sight Sciences, Inc.
  • 16.18. STAAR Surgical Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL GLAUCOMA SURGERY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL GLAUCOMA SURGERY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL GLAUCOMA SURGERY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL GLAUCOMA SURGERY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GLAUCOMA DRAINAGE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GLAUCOMA DRAINAGE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GLAUCOMA DRAINAGE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DRAINAGE IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DRAINAGE IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DRAINAGE IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LASER BASED DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LASER BASED DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LASER BASED DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OPEN ANGLE GLAUCOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OPEN ANGLE GLAUCOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OPEN ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CLOSED ANGLE GLAUCOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CLOSED ANGLE GLAUCOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CLOSED ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SILICONE BASED DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SILICONE BASED DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SILICONE BASED DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POLYPROPYLENE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POLYPROPYLENE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POLYPROPYLENE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OPHTHALMIC CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OPHTHALMIC CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OPHTHALMIC CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OFFLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OFFLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OFFLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 110. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 112. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. GCC GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 133. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. G7 GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 138. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 140. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. NATO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. CANADA GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. CANADA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. CANADA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. CANADA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. CANADA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. CANADA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. CANADA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. MEXICO GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. MEXICO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MEXICO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 162. MEXICO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MEXICO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. MEXICO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. MEXICO GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. BRAZIL GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. BRAZIL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. BRAZIL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 169. BRAZIL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRAZIL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. BRAZIL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRAZIL GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED KINGDOM GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED KINGDOM GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED KINGDOM GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED KINGDOM GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED KINGDOM GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED KINGDOM GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED KINGDOM GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GERMANY GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. GERMANY GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. GERMANY GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. GERMANY GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GERMANY GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. GERMANY GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. GERMANY GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. FRANCE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. FRANCE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. FRANCE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 190. FRANCE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. FRANCE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. FRANCE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. FRANCE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. RUSSIA GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. RUSSIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. RUSSIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. RUSSIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. RUSSIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. RUSSIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. RUSSIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. ITALY GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. ITALY GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ITALY GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. ITALY GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. ITALY GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. ITALY GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. ITALY GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. SPAIN GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. SPAIN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. SPAIN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 211. SPAIN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. SPAIN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. SPAIN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. SPAIN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. INDIA GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. INDIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. INDIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 225. INDIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. INDIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. INDIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. INDIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. JAPAN GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. JAPAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. JAPAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 232. JAPAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. JAPAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. JAPAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. JAPAN GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 239. AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)